Two law firms have launched a class action against NSW Health on behalf of over 10,000 junior doctors for its alleged failure to pay overtime hours.
Reports exposing serious government and healthcare failures amid Victoria’s second COVID-19 wave have strengthened the claims in class actions against the Andrews government and two aged care providers, according to the law firm behind the cases.
A unit of Johnson & Johnson has been ordered to pay around $40 million in legal costs to the lead applicants in a class action over pelvic mesh implants after a judge dismissed the company’s bid to stay the costs until after a high profile appeal is heard next year.
A judge has approved an application to join the insurer of a former doctor into a class action seeking compensation for defective pelvic mesh implants and wants to fast-track the matter for trial next year.
Two units of US drug giant Johnson & Johnson have filed a lawsuit seeking preliminary discovery from Juno Pharmaceuticals for a possible patent lawsuit over a popular chemotherapy drug used to treat blood cancer.
Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
A judge has enjoined Merck Sharpe and Dohme from launching its 15-valent pneumococcal conjugate vaccine after finding it would infringe claims of a Wyeth patent for its Prevnar 13 vaccine, despite MSD’s argument that barring it from launching the vaccine would be contrary to the public interest.
Pharmaceutical ingredients company Alkaloids of Australia and former export manager Christopher Joyce have been charged over a cartel following a price-fixing investigation by the ACCC linked to the active ingredient in stomach cramp drug Buscopan.
Two psychiatrists at the heart of the Chelmsford deep sleep therapy scandal have had their defamation cases against publisher HarperCollins dismissed ,with a judge finding the lawsuits were an attempt to “rewrite history” regarding harm done to patients receiving their controversial treatment.
The lead applicant in a class action against Bayer over allegedly defective Essure contraceptive devices will ask the court to discontinue its claims against two makers of the controversial medical implants.